Log In
Print
BCIQ
Print
Print this Print this
 

Dalantercept (ACE-041)

  Manage Alerts
Collapse Summary General Information
Company Acceleron Pharma Inc.
DescriptionAngiogenesis inhibitor that binds to and prevents members of the transforming growth factor (TGF) beta superfamily from signaling through ALK1
Molecular Target Activin receptor-like kinase 1 (ACVRL1) (ALK1) (HHT2)
Mechanism of ActionAngiogenesis inhibitor
Therapeutic ModalityBiologic

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today